← All Investors
SUMMIT THERAPEUTICS INC
SMMT
Holders
6
Combined Value
$53M
Combined Shares
2,842,874
Current Price
$14.07
52W High
$30.98
vs 52W High
−54.6%
Investor Activity
BUYSELLImplied priceClick a quarter to see who traded
Held By
| Investor | Value | % of Portfolio | Avg Buy Price | Gain | Last Activity | As of |
|---|---|---|---|---|---|---|
| Ken Griffin - Citadel Advisors | $20M | 0.00% | ~$18.52 | −24.0% | Sold Q1 2026 | Q1 2026 |
| Steve Cohen - Point72 | $15M | 0.02% | ~$18.96 | −25.8% | Bought Q1 2026 | Q1 2026 |
| Cliff Asness - AQR Capital | $8.1M | 0.00% | ~$18.36 | −23.4% | Bought Q1 2026 | Q1 2026 |
| Paul Tudor Jones - Tudor Investment | $7.5M | 0.01% | ~$20.09 | −30.0% | Sold Q1 2026 | Q1 2026 |
| Israel Englander - Millennium Management | $2.4M | 0.00% | ~$16.24 | −13.4% | Sold Q1 2026 | Q1 2026 |
| Joel Greenblatt - Gotham Asset Management | $298K | 0.00% | ~$7.80 | +80.4% | Sold Q3 2025 | Q1 2026 |
Recent Activity
Ownership History
| Period | Holders | Total Shares | Δ Shares | Total Value | Implied Price |
|---|---|---|---|---|---|
| Q1 2026 | 6 | 2,842,874 | −37.6% | $53M | $18.85 |
| Q4 2025 | 5 | 4,554,706 | +107.2% | $79M | $17.48 |
| Q3 2025 | 5 | 2,197,778 | +6.3% | $45M | $20.66 |
| Q2 2025 | 4 | 2,067,267 | −29.7% | $43M | $21.28 |
| Q1 2025 | 5 | 2,941,157 | +1.6% | $56M | $19.29 |
| Q4 2024 | 5 | 2,896,010 | +3.6% | $51M | $17.85 |
| Q3 2024 | 5 | 2,795,105 | +25.1% | $61M | $21.90 |
| Q2 2024 | 4 | 2,233,772 | — | $17M | $7.80 |